Correlation Between AB Volvo and Xbrane Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AB Volvo and Xbrane Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AB Volvo and Xbrane Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AB Volvo and Xbrane Biopharma AB, you can compare the effects of market volatilities on AB Volvo and Xbrane Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AB Volvo with a short position of Xbrane Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of AB Volvo and Xbrane Biopharma.

Diversification Opportunities for AB Volvo and Xbrane Biopharma

0.77
  Correlation Coefficient

Poor diversification

The 3 months correlation between VOLV-B and Xbrane is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding AB Volvo and Xbrane Biopharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xbrane Biopharma and AB Volvo is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AB Volvo are associated (or correlated) with Xbrane Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xbrane Biopharma has no effect on the direction of AB Volvo i.e., AB Volvo and Xbrane Biopharma go up and down completely randomly.

Pair Corralation between AB Volvo and Xbrane Biopharma

Assuming the 90 days trading horizon AB Volvo is expected to generate 0.08 times more return on investment than Xbrane Biopharma. However, AB Volvo is 12.61 times less risky than Xbrane Biopharma. It trades about 0.07 of its potential returns per unit of risk. Xbrane Biopharma AB is currently generating about -0.01 per unit of risk. If you would invest  21,774  in AB Volvo on September 1, 2024 and sell it today you would earn a total of  5,386  from holding AB Volvo or generate 24.74% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy99.63%
ValuesDaily Returns

AB Volvo  vs.  Xbrane Biopharma AB

 Performance 
       Timeline  
AB Volvo 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in AB Volvo are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong essential indicators, AB Volvo is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
Xbrane Biopharma 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Xbrane Biopharma AB are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Xbrane Biopharma sustained solid returns over the last few months and may actually be approaching a breakup point.

AB Volvo and Xbrane Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AB Volvo and Xbrane Biopharma

The main advantage of trading using opposite AB Volvo and Xbrane Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AB Volvo position performs unexpectedly, Xbrane Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xbrane Biopharma will offset losses from the drop in Xbrane Biopharma's long position.
The idea behind AB Volvo and Xbrane Biopharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance